Ascension returned to profitability in 2025
The return to profitability is a victory for the system, which reported a $1 billion loss last year as it struggled to recover from a cyberattack.
Uncategorized
CDC advisers postpone vote to delay some newborns’ hepatitis B shot
Members of ACIP postponed a planned vote on withholding some infants’ first hepatitis B vaccine dose, adding more confusion to an already muddied meeting.
CDC advisers postpone vote to delay some newborns’ hepatitis B shot Read More »
Biogen to buy startup Alcyone, eyeing easier delivery of RNA drugs
The purchase gives Biogen full access to an implantable device that could help patients avoid the repeat lumbar punctures required for drugs like Spinraza.
Biogen to buy startup Alcyone, eyeing easier delivery of RNA drugs Read More »
STEM en México: dónde están los sueldos altos y qué habilidades los sostienen
Los sueldos altos aparecen donde hay escasez de talento y efecto directo en resultados: ingeniería que evita paros, software que mueve ventas, análisis que reduce pérdidas, ciberseguridad que protege activos. El patrón es claro: tareas difíciles de reemplazar, deci …
STEM en México: dónde están los sueldos altos y qué habilidades los sostienen Read More »
Bye Bye Bluebird: Gene Therapy Biotech Emerges From Private Buyout With Rebrand
bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new path forward for manufacturing.
Bye Bye Bluebird: Gene Therapy Biotech Emerges From Private Buyout With Rebrand Read More »
Reformed ACIP Recommends Delaying MMRV Combo Vaccination, Forecasts Changes to Hep B, COVID
BMO Capital Markets analysts said the first day of the CDC vaccine advisory committee meeting Thursday had anti-vaccine overtones as the panel, which was revamped by Health Secretary Robert F. Kennedy, Jr. in June, voted to recommend that children under four receive the measles, mumps, rubella (MMR) vaccine separately from a chickenpox vaccine. Today the
Nektar Provides More Data for Dermatitis Drug, but Key Questions Remain Unanswered
Nektar Therapeutics still needs to establish what differentiates rezpeg from other atopic dermatitis therapies, according to analysts at William Blair.
Nektar Provides More Data for Dermatitis Drug, but Key Questions Remain Unanswered Read More »
Hope for Rare Pediatric Disease Voucher Reignited as House Bill Passes Committee
The House Committee on Energy and Commerce has cleared proposed legislation that could bring back the FDA’s rare pediatric priority review voucher program, which allows for expedited drug reviews.
Hope for Rare Pediatric Disease Voucher Reignited as House Bill Passes Committee Read More »
Replimune Crashes as Uncertainty Clouds Regulatory Path for Tumor Destroyer
Investors had been “holding out hope” that there remained a regulatory path forward for RP1, but results of Replimune’s Type A meeting with the FDA do not appear to support this, according to BMO Capital Markets.
Replimune Crashes as Uncertainty Clouds Regulatory Path for Tumor Destroyer Read More »
Perseverance explora en Marte un terreno con rocas antiquísimas
Recientemente, el róver robótico Perseverance de la NASA, que desde su llegada a la superficie de Marte en 2021 recorre y explora terrenos del Planeta Rojo, entró en una zona repleta de rocas de muy distintos tipos que, según el equipo científico de la misió …
Perseverance explora en Marte un terreno con rocas antiquísimas Read More »